Short peptides derived from the NH2-terminus of subclass IIa bacteriocin enterocin CRL35 show antimicrobial activity

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 6, 2007, Pages 1102-1108

  Salvucci, Emiliano ^a   Saavedra, Lucila ^a   Sesma, Fernando ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Enterococci; Liposomes; Pediocin

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIOCIN; ENTEROCIN CRL35; MESENTERICIN 105; PEDIOCIN PA 1; PISCICOLIN 126; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AGAR MEDIUM; AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CELL KINETICS; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; CULTURE MEDIUM; DIFFUSION; FLUORESCENCE ANALYSIS; GROWTH INHIBITION; IN VITRO STUDY; LISTERIA INNOCUA; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIOCINS; CULTURE MEDIA; KINETICS; LISTERIA; LISTERIA MONOCYTOGENES; MEMBRANE POTENTIALS; MICROBIAL SENSITIVITY TESTS; PEPTIDES;

EID: 34447567289     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm096     Document Type: Article

References (33)

1. Riley MA, Wertz JE. Bacteriocins: Evolution, ecology, and application. Annu Rev Microbiol 2002; 56: 117-37.
2. Bierbaum G, Sahl HG. Influence of cationic peptides on the activity of the autolytic endo-β-N-acetylglucosaminidase of Staphylococcus simulans 22. FEMS Microbiol Lett 1989; 49: 223-8.
3. Hechard Y, Sahl H. Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie 2002; 84 545-57.
4. Martínez-Cuesta MC, Kok J, Herranz E et al. Requirement of autolytic activity for bacteriocin-induced lysis. Appl Environ Microbiol 2000; 66: 3174-9.
5. Morisset D, Berjeaud JM, Marion D et al. Mutational analysis of mesentericin Y105, an anti-Listeria bacteriocin, for determination of impact on bactericidal activity, in vitro secondary structure, and membrane interaction. Appl Environ Microbiol 2004; 70: 4672-80.
6. Papagianni M. Ribosomally synthesized peptides with antimicrobial properties: Biosynthesis, structure, function, and applications. Biotechnol Adv 2003; 21: 465-99.
7. Fimland G, Johnsen L, Dalhus B et al. Pediocin-like antimicrobial peptides (class lla bacteriocins) and their immunity proteins: biosynthesis, structure, and mode of action. J Pept Sci 2005; 11: 688-96.
8. Minahk CJ, Dupuy F, Morero RD. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35. J Antimicrob Chemother 2004; 53: 240-6.
9. Johnsen L, Fimland G, Nissen-Meyer J. The C-terminal domain of pediocin-like antimicrobial peptides (class lla bacteriocins) is involved in specific recognition of the C-terminal part of cognate immunity proteins and in determining the antimicrobial spectrum. J Biol Chem 2005; 280: 9243-50.
10. Cotter PD, Hill C, Ross RP. Bacteriocins: Developing innate immunity for food. Nat Rev Microbiol 2005; 3: 777-88.
11. Bhugaloo-Vial P, Douliez JP, Moll D et al. Delineation of key amino acid side chains and peptide domains for antimicrobial properties of divercin V41, a pediocin-like bacteriocin secreted by Carnobacterium divergens V41. Appl Environ Microbiol 1999; 65: 2895-900.
12. Fleury Y, Dayem MA, Montagne JJ et al. Covalent structure, synthesis, and structure-function studies of mesentericin Y 105(37), a defensive peptide from gram-positive bacteria Leuconostoc mesenteroides. J Biol Chem 1996; 271: 14421-9.
13. Fimland G, Jack R, Jung G et al. The bactericidal activity of pediocin PA-1 is specifically inhibited by a 15-mer fragment that spans the bacteriocin from the center toward the C terminus. Appl Environ Microbiol 1998; 64: 5057-60.
14. Yan LZ, Gibbs AC, Stiles ME et al. Analogues of bacteriocins: antimicrobial specificity and interactions of leucocin A with its enantiomer, camobacteriocin B2, and truncated derivatives. J Med Chem 2000; 43: 4579-81.
15. Saavedra L, Minahk C, de Ruiz Holgado AP et al. Enhancement of the enterocin CRL35 activity by a synthetic peptide derived from the NH2-terminal sequence. Antimicrob Agents Chemother 2004; 48: 2778-81.
16. Tsai HN, Hodgson DA. Development of a synthetic minimal medium for Listeria monocytogenes. Appl Environ Microbiol 2003; 69: 6943-5.
17. Gasson MJ. Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol 1983; 154: 1-9.
18. Chopin A, Chopin MC, Moillo-Batt A et al. Two plasmid-determined restriction and modification systems in Streptococcus lactis. Plasmid 1984; 11: 260-3.
19. Métivier A, Pilet MF, Dousset X et al. Divercin V41, a new bacteriocin with two disulphide bonds produced by Camobacterium divergens V41: Primary structure and genomic organization. Microbiology 1998; 144: 2837-44.
20. Saavedra L. Péptidos antimicrobianos producidos por enterococos: análísis bioquímico y molecular. PhD Thesis. 2005. Universidad Nacional de Tucumán, Tucumán, Argentina.
21. Saavedra L, Castellano P, Sesma F. Purification of bacteriocins produced by lactic acid bacteria. In: Spencer JFT, Ragout de Spencer AL, eds. Public Health Microbiology. Methods and Protocols. Totowa, NJ: Humana Press, 2004; 268: 331-6.
22. Breewer P, Abee T. Assessment of the membrane potential, intracellular pH and respiration of bacteria employing fluorescence techniques. In: Kowalchuk GA, de Bruijn FJ, Head IM et al., Molecular Microbial Ecology Manual. Second Edition. The Netherlands: Kluwer Academic Publishers, 2004; 1563-80.
23. de Arcuri BF, Vechetti GF, Chehín RN et al. Protein-induced fusion of phospholipid vesicles of heterogeneous sizes. Biochem Biophys Res Commun 1999; 262: 586-90.
24. McAuliffe O, Ryan P, Ross RP et al. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl Environ Microbiol 1998; 64: 439-45.
25. Hoover DM, Wu Z, Tucker K et al. Antimicrobial characterization of human β-defensin 3 derivatives. Antimicrob Agents Chemother 2003; 47: 2804-9.
26. Bobek LA, Situ H. MUC7 20-mer: Investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action. Antimicrób Agents Chemother 2003; 47: 643-52.
27. Sitaram N, Sai KP, Singh S et al. Structure - function relationship studies on the frog skin antimicrobial peptide tigerinin 1: design of analogs with improved activity and their action on clinical bacterial isolates. Antimicrob Agents Chemother 2002; 46: 2279-83.
28. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-95.
29. Song YM, Park Y, Lim SS et al. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Biochemistry 2005; 44: 1.
30. Tsubery H, Yaakov H, Cohen S et al. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria. Antimicrob Agents Chemother 2005; 49 3122-8.
31. Yenugu S, Hamil KG, Birse CE et al. Antibacterial properties of the sperm-binding proteins and peptides of human epididymis 2 (HE2) family; salt sensitivity, structural dependence and their interaction with outer and cytoplasmic membranes of Escherichia coli. Biochem J 2003; 372: 473-83.
32. Haugen HS, Fimland G, Nissen-Meyer J et al. Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide curvacin A. Biochemistry 2005; 44: 16149-57.
33. Abee T. Opportunities for bacteriocins in food: Prevention and Safety. In: Gaukel V, Spiess WEL, eds. European Research Towards Safer and Better Food Proceedings Part 1. 3rd Karlsruhe Nutrition Symposium. Bundesforschungsanstalt für Emährung, Karlsruhe, Germany: 1998; 42-50.